Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000289·Dyne Therapeutics, Inc.
Schedule 13G ownership disclosure
Dyne Therapeutics Inc
Common Stock · CUSIP: 26818M108
Event date: 2025-09-30
- Filing-level shares
- 14,745,505
- Percent of class
- 10.4%
- JANUS HENDERSON GROUP PLC
Shares: 14,745,505 · Class: 10.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000289
- Form type
- SCHEDULE 13G/A
- Filer
- Dyne Therapeutics, Inc.
- CIK
- CIK 1818794
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership